{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:43:56Z","timestamp":1765079036720},"reference-count":25,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":392,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,11,27]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Studies assessing the efficacy of triple therapy containing clarithromycin and amoxicillin for the eradication of <jats:italic>Helicobacter pylori<\/jats:italic> infection and healing of duodenal ulcers in Asian and African countries are limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To determine the efficacy and safety of 1\u2010week triple therapy with omeprazole, amoxicillin and clarithromycin for eradicating <jats:italic>H. pylori<\/jats:italic> infection in patients with active duodenal ulcer living in Asian and African regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>This was an open\u2010label, multicentre study in 11 centres in Asia and Africa. Patients with endoscopy\u2010proven duodenal ulcer and who were <jats:italic>H. pylori<\/jats:italic>\u2010positive were treated with clarithromycin 500\u2003mg, omeprazole 20\u2003mg, and amoxicillin 1000\u2003mg, all given twice daily for 7\u2003days. Upper endoscopy was repeated at week 6 to check for ulcer healing and <jats:italic>H. pylori<\/jats:italic> status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>A total of 117 patients were recruited. <jats:italic>H. pylori<\/jats:italic> eradication rates were 85% by per protocol analysis and 80% by intention\u2010to\u2010treat analysis. Ulcer healing was found in 94% of subjects (per protocol analysis). Clinical success, measured by change of pre\u2010treatment ulcer symptoms, was strongly supported by complete resolution or improvement in 100% of the evaluable patients (per protocol analysis). Since treatment\u2010related adverse events, when present, were largely mild or moderate, the triple therapy regimen was considered safe.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Seven\u2010day triple therapy with omeprazole, amoxicillin, and clarithromycin was efficacious for treating Asian and African patients with duodenal ulcer disease associated with <jats:italic>H. pylori<\/jats:italic> infection, and the treatment regimen was well\u2010tolerated.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00863.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:40:11Z","timestamp":1047354011000},"page":"1529-1535","source":"Crossref","is-referenced-by-count":31,"title":["Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of <i>Helicobacter pylori<\/i> in duodenal ulcer patients in Asia and Africa"],"prefix":"10.1111","volume":"14","author":[{"given":"B. C. Y.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. R.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Van Rensburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Simjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. S.","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Seebaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Destefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91111-8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-9-705"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.43"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613015"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02389515"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00477.x"},{"key":"e_1_2_6_8_2","first-page":"675","article-title":"Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence","volume":"91","author":"Porro G","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00234.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.111282000.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.035_c.x"},{"key":"e_1_2_6_13_2","first-page":"9","article-title":"One\u2010week low\u2010dose triple therapy for the eradication of Helicobacter pylori infection","volume":"7","author":"Labenz J","year":"1994","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199409000-00004"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00537.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00003.x"},{"key":"e_1_2_6_17_2","first-page":"A138","article-title":"Helicobacter pylori resistance to antimicrobial agents and its influence on clinical outcome","volume":"112","author":"Megraud F","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.5.675"},{"key":"e_1_2_6_19_2","first-page":"784","article-title":"In vitro antibiotic sensitivity of H. pylori","volume":"83","author":"Greig A","year":"1993","journal-title":"S Afr Med J"},{"key":"e_1_2_6_20_2","first-page":"A138","article-title":"Antimicrobial resistance of Helicobacter pylori in Korean duodenal ulcer patients","volume":"112","author":"Han D","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(05)80032-5"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1997.tb00065.x"},{"key":"e_1_2_6_23_2","first-page":"651","article-title":"Duodenal ulcer healing after 7\u2010day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin","volume":"33","author":"Schultze K","year":"1995","journal-title":"Z Gastroenterol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.6.735"},{"key":"e_1_2_6_25_2","first-page":"261","article-title":"Antimicrobial susceptibility pattern and biotyping of Helicobacter pylori isolates from patients with peptic ulcer disease","volume":"102","author":"Sharma S","year":"1995","journal-title":"Indian J Med Res"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.1999.01814.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00863.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00863.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00863.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:02:42Z","timestamp":1698566562000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00863.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,27]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11,27]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00863.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00863.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11,27]]}}}